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Abstract
Protein lysine acetylation networks can regulate central processes such as carbon metabolism and
gene expression in bacteria. In Escherichia coli, cyclic-AMP (cAMP) regulates protein lysine
acetyltransferase (PAT) activity at the transcriptional level, but in Mycobacterium tuberculosis,
fusion of a cyclic-nucleotide binding domain to a Gcn5-like PAT domain enables direct cAMP
control of protein acetylation. Here we describe the allosteric activation mechanism of M.
tuberculosis PAT. The crystal structures of the auto-inhibited and cAMP-activated PAT reveal that
cAMP binds to a cryptic site in the regulatory domain over 32 Å from the catalytic site. An
extensive conformational rearrangement relieves auto-inhibition by a substrate-mimicking lid that
covers the protein-substrate binding surface. A steric double latch couples the domains by
harnessing a classic, cAMP-mediated, conformational switch. The structures suggest general
features that enable the evolution of long-range communication between linked domains.
Keywords
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Protein domains have long been recognized as functionally modular 1. Domain shuffling in
exons in eukaryotes, for example, enables rapid duplication and divergence of protein
families 2,3. Recombination produces numerous assortments of domains that mediate hybrid
processes 4, and domain fusions signal cooperating activities 5. Kuriyan and Eisenberg
proposed that fusions are a common initial step in the evolution of allosteric regulation 6, but
this view of the structural autonomy of domains like beads on a string has turned attention
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taway from the problem of how domains evolve to work in concert to enable tight functional
regulation 7. Here we explore the particularly dramatic mechanisms of functional domain
interdependence in the cyclic-AMP-regulated protein lysine acetyl transferase (PAT) of
Mycobacterium tuberculosis.
Reversible protein acetylation is an important regulatory mechanism that controls numerous
cellular processes in all three kingdoms of life 8,9. Proteomic studies in prokaryotes and
eukaryotes have detected thousands of lysine-acetylated proteins, a number that rivals
phosphoproteins 9. Protein lysine acetylation controls diverse cellular processes, including
chromatin structure, chromosomal segregation, cytoskeletal dynamics, and chaperone
function. The emerging role for this modification in controlling mitochondrial
metabolism 10,11 highlights the remarkable conservation of this regulatory strategy. Recent
discoveries have revealed that protein lysine acetylation globally regulates carbon
metabolism in diverse bacterial species 12-14. Stimuli such as different carbon sources alter
acetylation patterns of >100 proteins in Escherichia coli and Salmonella to change the
direction of carbon flux to glycolysis or gluconeogenesis and to control the activity of the
glyoxylate shunt relative to the TCA cycle. However, distinct networks couple protein
acetylation to growth conditions in prokaryotes 15.
In enteric bacteria, Gcn5-related N-acetyltransferase (GNAT) PAT activity is controlled at
the transcriptional level 16. Increases in the concentration of cyclic-AMP (cAMP), a
universal second messenger that modulates diverse functions in response to environmental
conditions, indirectly mediate this transcriptional stimulation. The cAMP complex of the
catabolite activator protein (CAP) induces the expression of genes for pathways required for
the utilization of alternative carbon sources or, in the absence of other substrates,
restructures central carbon metabolism for slow growth 17. Indeed, cAMP has been shown to
be the dominant regulator controlling carbon fluxes in glucose-limited cultures. The E. coli
patZ acetyltransferase gene, for example, is activated ~10-fold by entry into stationary phase
or growth on acetate compared to growth on glucose 16. Binding of the CAP-cAMP
complex to two sites in the patZ promoter mediates this transcriptional activation.
In contrast in M. tuberculosis, cAMP directly activates the single Gcn5-like enzyme,
Rv0998 18, which we call Mt-PatA. Cyclic-AMP mediates this allosteric regulation by
binding to a cyclic-nucleotide binding domain fused to the N-terminus of the catalytic PAT
domain 18. While the substrates of Mt-PatA have not been globally identified, it has been
proposed to inhibit the acetate catabolic enzyme, acetyl-CoA synthetase (ACS) 19. Although
no conditions have been found in which Mt-PatA acetylates purified ACS in vitro, the
purified Mycobacterium smegmatis ortholog (MSMEG_5458) acetylates both M. smegmatis
and M. tuberculosis ACS 19. The universal stress protein (USP; MSMEG_4207), a homolog
of proteins involved in adaptation to growth-limiting conditions 20, is an in vitro substrate of
both mycobacterial PatA enzymes 18. M. tuberculosis lacks a USP protein, however, making
USP a nonphysiological substrate. Nonetheless, in vitro USP acetylation has enabled the
characterization of Mt-PatA activity and regulation 18. The M. tuberculosis NAD+-
dependent deacetylase, Rv1151c, reverses Mt-PatA modifications and creates a reversible
protein acetylation system 18,19.
The biological functions of Mt-PatA in adapting to different carbon sources and shifting to
slow growth appear to have been conserved across diverse bacteria 12-14,21, but the allosteric
mechanism by which cAMP regulates protein acetylation is specific to mycobacteria. To
understand how distinct, functionally independent domains can be fused to enable this
unique control strategy, we determined the structures of the auto-inhibited and cAMP-
activated states of Mt-PatA. We found that sequences inserted in the PAT domain
simultaneously regulate the accessibility of the regulatory and catalytic sites. This switch
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tharnesses a dramatic conformational transition in the cAMP regulatory module to control
the exposure of the catalytic site over 32 Å away in the structures. The Mt-PatA structures
afford unanticipated insights into the functional requirements of the evolutionary steps
following domain fusion that amplify emergent allosteric regulation.
RESULTS
Structure of Mt-PatA
The Mt-PatA sequence contains an N-terminal cNMP-binding domain (residues 12-142)
fused to a GNAT-family catalytic domain (residues 146-314) followed by a C-terminal
extension (residues 315-333). To determine how the regulatory and catalytic domains are
linked together to enable cAMP to control catalytic activity, we determined the crystal
structures of the auto-inhibited and active forms of the enzyme (Table 1). Despite the
absence of acetyl-CoA in the crystallization conditions, the structures contained this
substrate carried through the purification from intracellular pools. We determined the
structure of the active cAMP complex in two crystal forms at 1.8- and 2.8-Å resolution.
Because the structures of monomers derived from different space groups are similar (root-
mean-square deviation (rmsd) = 0.70 Å for all 327 Cα atoms), the higher resolution
structure was used to represent the active conformation.
The 1.7-Å-resolution structure of Mt-PatA in the absence of cAMP (Fig. 1a) reveals that at
least two mechanisms autoinhibit the enzyme. The first domain adopts the fold of a typical
cAMP-binding regulatory module (Supplementary Fig. 1a), but remarkably, the C-terminus
of the protein occupies the cAMP-binding site, excluding the ligand (Fig. 1b). The C-
terminal extension forms a helix that is just long enough to project the terminal carboxylate
into the cryptic activator site, where it structurally mimics a bound cyclic phosphate group.
A short extended loop (residues 143-145) packed against the C-terminal helix tightly links
the two functional domains. The PAT domain shows structural homology to the GNAT
family (Supplementary Fig. 1c). Acetyl-CoA binds in a shallow cleft formed by structurally
conserved motifs 22 (Fig. 1c). Unexpectedly, a large loop (residues 161-203) integrated into
the catalytic domain forms a lid that folds over the catalytic site and excludes protein
substrates (Fig. 1a). His173 in the lid engages the predicted catalytic base, Glu235, and the
activated acetyl group, analogous to a lysine substrate (Fig. 1d). Thus, the C-terminal helix
and the lid represent dedicated regulatory elements of the PAT domain that form a steric
double latch that limits enzyme activity. The regulatory and catalytic sites are separated by
over 32 Å, raising the question of the mechanism of long-range communication between the
domains.
Structure of the active Mt-PatA:cAMP:Ac-CoA complex
Dramatic conformational changes accompany cAMP binding to the regulatory domain (Fig.
2). A difference-distance matrix reveals relative structural shifts of up to 40 Å (Fig. 2a). The
regulatory domain pivots ~40° around Ser144 in the interdomain linker, resulting in a
strikingly different orientation with respect to the catalytic domain (Fig. 2b). This rotation
removes the C-terminus from the cAMP binding site. In the cAMP-activated Mt-PatA, the
44-residue lid refolds, exposing the catalytic site, further burying the Ac-CoA substrate and
revealing a conserved surface adjacent to the substrate-binding site (Fig. 2c).
Tertiary changes in regulatory domain stabilized by cAMP are coupled to release of the lid
from the PAT active site. While the topology of the regulatory domain is retained in the
auto-inhibited and active forms (rmsd = 2.76 Å for all 134 Cα atoms), the β-sheet is the
rigid element in the structure (Cα rmsd = 0.85 Å for residues 37-113; Fig. 3a). The α-
helices that start and end the domain shift and undergo tertiary structural changes
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t(Supplementary Fig. 2a). Rotating around Gly113, helices C (residues 26-35), E (residues
115-123) and F (residues 127-142) move >10 Å relative to the sheet to enable Arg138 and
Phe142 to sandwich the adenine ring against Val67 in the sheet (Figs. 3a, 3b). This altered
conformation of helix F completes the cAMP binding site.
To define the side-chain shifts that enable these large structural changes, we systematically
compared the rotamer distributions in the auto-inhibited and cAMP-activated structures
using the program Ringer 23. Ringer automatically samples the electron density map around
each side-chain dihedral angle, and the correlation coefficients (ccs) of Ringer plots can
highlight changes in rotamer ensembles even when the underlying models are similar 23,24.
While distributions with ccs <0.5 often differ the major populated rotamer, a conservative cc
threshold of 0.2 was used to automatically define sites that switch rotamers between the two
structures (Supplementary Figs. 2b, 2c). In typical control structures in the PDB where
changes in crystal packing are the only perturbations, very few residues give Ringer
correlation coefficients <0.2 (Supplementary Figs. 2d, 2e). In contrast, Mt-PatA, activation
is associated with extensive remodeling of side-chain distributions (Figs. 3c and 3d;
Supplementary Fig. 2c). Residues in helices A, B, C and E, as well as the underlying β-sheet
of the regulatory domain, adopt new rotamers upon cAMP binding (Fig. 3c). The refolding
of the lid remodels rotamers on the surface of the protein from helix E all the way to the
active site (Fig. 3d; Supplementary Fig. 2c). The newly exposed, conserved surface (Fig. 2c)
near the acetyl donor populates many new rotamers. The core of the PAT domain and most
of the C-terminal helix, in contrast, retain similar structures upon activation.
Communication between the regulatory and catalytic domains
Comparison of the structures reveals that the regulatory and catalytic domains communicate
with each other by forming sterically incompatible conformations in the active and auto-
inhibited states. In the auto-inhibited state, helix F of the regulatory domain is nearly parallel
to helix I (residues 193-202) of the lid domain. However, helix F reorients in the active
conformation due to the rotation of the regulatory domain, which requires a movement of
the lid to avoid steric clashes between these helices (Fig. 3e). The lid domain refolds into a
distinct backbone arrangement (Supplementary Fig. 3a). Many lid residues move >15 Å, and
helix I rotates toward the catalytic domain by 65° (Fig. 3e). Cyclic AMP favors the “open”
state of the two steric latches by stabilizing a rotation of the regulatory domain that creates
the activator binding site and simultaneously generates a steric clash with the inhibitory
structure of the lid. Refolding of the lid enables the rotation of the regulatory domain that
creates the cAMP binding site.
The comparison of active and auto-inhibited structures suggests that activation by cAMP
stabilizes the open lid. To test this two-state coupling model, we took advantage of the
mimicry of a bound substrate by His173 in the auto-inhibited conformation. The lack of
conservation of this residue in the closely related M. smegmatis ortholog suggests that its
main role is to block substrate access in the absence of cAMP. The His173Lys substitution
introduced the only Lys in the sequence. Consistent with the close approach of His173 to the
acetyl donor (Fig. 1d), we found that the His173Lys mutant readily auto-acetylated the new
lysine in the absence of cAMP (Fig. 4a). Addition of cAMP blocked this auto-acetylation,
consistent with the structure of the active state in which His173 in the open lid is 25 Å away
from the acetyl donor (Supplementary Fig. 3b). In contrast, cAMP stimulated acetylation of
M. smegmatis USP by the His173Lys variant (Fig. 4b), indicating that the mutation did not
alter the normal regulation of the enzyme.
A two-state model further predicts that the auto-inhibited structure stabilizes the closed
conformation of the lid in which the acetyl-Lys173 is buried, while cAMP stabilizes active
form in which residue 173 is fully solvent exposed. To test the accessibility of acetyl-
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tLys173, we measured the activity of the deacetylase, Rv1151c, in the presence and absence
of cAMP. Under conditions in which the auto-acetylated Mt-PatA His173Lys was fully
deacetylated in <10 min in the presence of cAMP, the auto-inhibited form protected acetyl-
Lys173 for >2 hours (Fig. 4c). In contrast, cAMP does not affect the deacetylation of a
control substrate, M. smegmatis USP (Fig. 4c). These results suggest that the lid is not
simply a flexible element, but rather that it forms alternate structures in the presence and
absence of cAMP in agreement with the distinct arrangements observed in the crystal
structures of the active and auto-inhibited states (Figs. 2b, 3e; Supplementary Fig. 3).
To investigate the role of the C-terminal helix in forming a steric latch, we changed the
length of the protein by adding or subtracting residues. Interestingly, deleting the last four
residues, which removes the C-terminus from the cAMP binding site, preserved activity and
activation by cAMP, but imparted low acetyl-transfer activity even in the absence of the
activator (Fig. 4d). Strikingly, compared to the −4 deletion, addition of one residue (Ser or
Arg) at the C-terminus activated the protein more strongly in the absence of cAMP. The
deletion of four residues or addition of a single residue also accelerated deacetylation of
His173Lys variants (Supplementary Fig. 4), suggesting that these mutations preferentially
destabilize the auto-inhibited conformation. In contrast, deletions of up to three residues that
maintain important contacts in the auto-inhibited structure (including the polar network
formed by Asp73, Arg326 and Glu330 (Supplementary Fig. 4h)) preserved the auto-
inhibition and the deacetylation pattern. Moreover, non-physiological high concentrations of
cGMP and cCMP also activated the enzyme (Supplementary Fig. 5a), and mutations of
conserved residues in the cAMP binding site blocked activation (Fig. 4e). These results
implicate the C-terminal steric latch in the switch in the conformation of helix F and the
rotation of the regulatory domain in activating the enzyme. The activation by C-terminal
insertions or deletions suggests that cAMP stabilizes an intrinsic active population, rather
than inducing a specific new structure.
Activity of the PAT domain
The central catalytic core of the PAT domain is structurally homologous to other GNAT-
family proteins (Supplementary Fig. 1c). In the active conformation, the open lid forms a
conserved surface adjacent to the substrate-binding site (Fig. 2c) that creates a narrow tunnel
that allows the substrate Lys side chain to access to the acetyl donor (Fig. 5a). The entrance
to the cavity is surrounded by Glu235, the conserved catalytic base, Arg184, which is
positioned to reduce the pKa of the substrate Lys, and the hydrophobic surfaces of side
chains (e.g. Phe185, Arg223, Val225, and Ala237), that can complement the aliphatic tail of
the Lys acceptor (Fig. 5b). Arg184 is particularly interesting, as it is buried under the lid and
Phe185, and it forms a hydrogen bond to the adjacent Arg223 at the bottom of a water-filled
tunnel on the backside of the lid (Figs. 5a, 5b). Upon activation, lid residues Arg184 and
Phe185 shift >25 Å (Supplementary Figs. 3b, 3c).
Mutational analysis emphasizes the importance of these residues for catalyzing acetyl
transfer. The Glu235Ala mutation abolished detectable transfer activity and mutations of
residues potentially involved in the complementary interaction with the aliphatic tail of the
substrate Lys significantly decreased (Arg223Ala, Val225Ala) or completely abolished
activity (Arg184Ala, Phe185Ala, Ala237Val) (Figs. 4e, 5c). The Arg223Ala variant showed
significantly reduced activity with an altered pH-rate profile (Fig. 5c). The Arg223Ala
mutation abolishes the direct interactions with Arg184, consistent with a dual role for this
network of residues in providing the binding site for the substrate and lowering the pKa of
the Lys-ε-amino-group nucleophile.
The presence of a cavity beyond the acetyl donor led us to measure the relative activities
with different substrates (acetyl-CoA, propionyl-CoA, and butyryl-CoA) on USP, a
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theterologous, noncognate protein substrate (Supplementary Fig. 5b-d). The addition of an
excess of an equimolar mixture of the three CoA donors resulted in 1.0:1.6:1.3 ratio of
acetyl-:propionyl-:butyryl-USP (Supplementary Fig. 5e). These results suggest Mt-PatA can
efficiently turn over alternative acyl donors. Accordingly, it may be fruitful to characterize
the distributions and functions of these alternative modifications in cells. As acetylation and
propionylation have been shown to regulate pathways necessary for the assimilation of
acetate and propionate, respectively19,25, it will be of interest to determine if these
modifications have distinct effects on target enzymes.
DISCUSSION
In this work, we have defined the unique mechanism by which mycobacteria couple cAMP
concentration to protein lysine acetylation. Our structural and biochemical analysis defines
two distinct functional states of the acetyltransferase, Mt-PatA. Dramatic structural changes
required for cAMP binding are coupled to exposure of the catalytic site. In the auto-inhibited
state, cAMP-binding site is blocked by the C-terminal helix from the catalytic domain. In
addition, the substrate-mimicking lid in the catalytic domain buries the acetyl donor and a
conserved surface that forms the protein-substrate-binding site. While excluding the C-
terminus, cAMP stabilizes the rotation of the regulatory domain as well as tertiary shifts that
are incompatible with the closed lid. These shifts release the steric double latch created by
the lid and the C-terminal extension of the PAT domain (Fig. 6). The lid rearranges in the
active state, creating a large binding surface for protein substrates.
Our results disfavor a sequential model in which cAMP binding initiates a specific
mechanical pathway for the conformational change. Importantly, there is no site for cAMP
to bind before the enzyme switches conformations (Fig. 1), and once cAMP stabilizes the
active form, the lid does not readily fluctuate back to the inhibited conformation (Figs. 2, 3,
4; Supplementary Figs. 3, 4). In addition, C-terminal mutations designed to destabilize the
latch at the regulatory site activate the enzyme in the absence of cAMP (Fig. 4d). This gain
of function shows that cAMP is not needed to induce the active conformation in the mutants.
These findings support a two-state model for activation mediated by steric incompatibility of
the alternate conformations. In this model, the relative stability of the two globally different
conformations mediates the communication between the regulatory and catalytic sites.
Consistent with changes in hydrogen exchange in peptides throughout the protein upon
cAMP binding 26, the widespread changes in rotamers detected using Ringer and the effects
of diverse mutations on activation provide evidence that changes in interactions all over the
enzyme determine the relative stability of the two states.
Diverse proteins containing a cAMP-binding module--including CAP, hyperpolarization-
activated cyclic nucleotide-modulated (HCN) channels, and the regulatory subunit of protein
kinase A--have been structurally characterized. Although these proteins mediate different
biological functions, they all contain a conserved module for cAMP binding that
allosterically controls activity 27,28. The cAMP-binding modules have similar architectures,
but show significant structural variations in the helical subdomain and the loop between
strands 4 and 5 (using Mt-PatA numbering; Supplementary Fig. 2). The core β-subdomain is
structurally similar (rmsd = 0.73-1.00 Å for ~70 Cα atoms of Mt-PatA (Supplementary Fig.
1a), and the key residues that interact with cAMP also are conserved among cAMP-binding
modules (Supplementary Fig. 1b).
Cyclic-AMP binding to Mt-PatA requires a >10 Å movement of helix F (residues 127-142)
in the regulatory domain. Similarly in E. coli CAP 28-30, cAMP stabilizes a restructuring in
the helix bearing cAMP-binding residues, linked to a coil-to-helix transition with many
residues moving >10 Å (Supplementary Figs. 6a-c). These changes result in steric clashes
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tthat are resolved by flipping out the CAP DNA-binding domains. The solution structure of
apo-CAP determined using NMR shows that the cAMP binding site is not present in the
major conformer in the absence of activator 28. Like the cryptic cAMP site of Mt-PatA, this
suggests that the conformation switches before the nucleotide binds. Moreover, NMR
measurements demonstrate that two constitutively activating CAP mutations switch the
population toward the active conformation in the absence of activator 28, as embodied in the
design of C-terminal mutants of Mt-PatA (Fig. 4d). In contrast, the cAMP binding site is
better formed in the crystal structure of apo-CAP, and the crystallographic results have been
interpreted in terms of a sequential activation model 30. Nonetheless, genetic, biochemical
and NMR studies of E. coli CAP 28 indicate that the two-state model for Mt-PatA activation
captures general features of cAMP-regulated systems.
Large structural shifts also occur in the RIα inhibitory subunit of human cAMP-dependent
protein kinase, where cAMP binding stabilizes dramatic conformational changes through the
connecting helix (αB/C) that release the regulatory subunit 31. These examples emphasize
the general role of the cAMP binding domain in regulating large conformational changes,
not subtle shifts 32. By modulating the position of the helical subdomain, cAMP binding
favors significant structural changes that must be accommodated in the attached functional
domains by changes that are commensurate in magnitude 32. While cAMP mediates large
shifts, the structural responses in regulated domains are distinct in different systems
(Supplementary Figs. 6d-g).
The selective pressures that shaped the evolution of cAMP regulation of Mt-PatA remain to
be defined. Bacterial pathogens including M. tuberculosis commonly utilize cAMP as an
important regulator of gene expression and host signaling to promote survival in changing
environmental conditions 15,33. The cellular dynamics of cAMP are determined by the
interplay of synthetic adenylyl cyclases (ACs) and hydrolytic cyclic nucleotide
phosphodiesterases (PDEs). The M. tuberculosis genome encodes 10 predicted cAMP-
binding proteins, one PDE, as well as an unusually large number of ACs (15 and 17 in
strains H37Rv and CDC1551, respectively) 34.
In contrast, other bacterial pathogens such as E. coli and Pseudomonas have only one AC
gene. This expansion of AC sequences suggests that Mt-PatA forms the nexus of multiple
signaling pathways that modulate cAMP levels. While the CAP transcription-factor family
mediates many of the effects of cAMP, the cAMP-signaling cascade in mycobacteria is
remodeled to mediate direct post-translational regulation of protein lysine acetylation
without the requirement for new gene expression 18. M. tuberculosis is thought to persist in
a relatively quiescent state during infection 35,36, and dormant mycobacteria may produce
little new mRNA or protein 37. Moreover, rapid changes in metabolism may be required to
tolerate host immune defenses. Thus, the structure of the Mt-PatA we describe may be
specialized to allow rapid regulation under growth-limiting conditions. The conservation of
the residues that contact cAMP (Supplementary Fig. 1b), however, may hamper efforts to
develop selective inhibitors that target this site in Mt-PatA in preference to human cAMP-
binding domains. Rather, control of the Mt-PatA latching mechanisms by stabilizing the
auto-inhibited form may afford a more promising strategy for therapeutic development.
While the evolutionary pathway cannot be appreciated experimentally, structural
comparisons afford clues to the molecular features that can enable the emergence of this
allosteric control. In Mt-PatA, two sequence elements in the catalytic domain and the three-
residue linker between the domains harness the conformational switch in the cAMP
regulatory module. The lid and the C-terminal helix inserted in the PAT domain do not
make direct contacts, but instead interact indirectly through the cAMP-binding module. No
regulation is possible without the lid, so this was likely the first regulatory element to be
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tincorporated. The archaeal PAT from Sulfolobus solfataricus provides an example of an
isolated PAT domain with an auto-inhibitory lid 38. Without a regulatory domain, the lid in
this archaeal PAT may respond directly to growth conditions. Consistent with the Kuriyan
and Eisenberg model 6, fusion of the cAMP binding domain in Mt-PatA and the evolution of
interdomain interactions with the lid in the unbound form would provide an evolutionary
pathway for metabolites to regulate auto-inhibition. The effects of C-terminal mutations in
Mt-PatA show that the addition of the C-terminal helix provides a latch that stabilizes the
auto-inhibited form relative to the active form, effectively increasing the cAMP
concentration needed for activation. The interdomain linker tightly tethers the domains,
preventing the regulatory and PAT domains from diffusing apart. This short covalent
linkage restricts the relative motions of the domains to a rotation that functions to reveal
cooperatively the cAMP binding site and the active site. This cooperativity of sterically
incompatible conformations creates a two-state mechanism of long-range communication
that couples regulatory and catalytic sites separated by over 32 Å. Overall, this switch in Mt-
PatA affords insights into the structural features that can be exploited in the evolution of
allosteric regulation through domain fusion.
Online Methods
Cloning of Mt-PatA and Rv1151c deacetylase from M. tuberculosis
The Rv0998 gene (GenBank™ accession number: CAB08156.1) was amplified by PCR
from the genomic DNA of Mycobacterium tuberculosis H37Rv using PfuTurbo DNA
polymerase (Stratagene), introducing unique BamHI and XhoI restriction sites at the N- and
C-termini, respectively. Amplified, digested PCR products were ligated into the predigested
pGEX-6P-3 vector (GE Healthcare), resulting in an N-terminal, cleavable, Glutathione-S-
transferase (GST) tag followed by the Mt-PatA coding sequence. Clones were verified by
DNA sequencing (Elim Biopharm).
Indel mutants of Mt-PatA were generated by PCR using the cloned wild-type Mt-PatA
construct as a template. Point mutations were generated using the QuikChange method
(Stratagene).
Cloning of universal stress protein MSMEG_4207 from M. smegmatis
The msmeg_4207 gene (GenBank™ accession number: ABK72172.1) was amplified from
the genomic DNA of Mycobacterium smegmatis MC2 155 by similar procedures described
above and cloned into the pGEX-6P-3 vector to introduce a cleavable N-terminal GST tag.
Clones were verified by DNA sequencing.
Protein expression and purification
Mt-PatA variants were expressed in BL21-CodonPlus™ (Stratagene) cells induced with 0.1
mM isopropyl β-D-thiogalactopyranoside (IPTG) and grown overnight at 22 °C. Cells were
harvested by centrifugation, resuspended in 20 mM Tris-HCl, pH 7.5, 100 mM NaCl with
protease inhibitors, lysed by sonication, and the cleared lysate was purified on a GSTrap™
HP column (GE Healthcare). Mt-PatA-GST fractions were cleaved with PreScission
Protease (GE Healthcare), reloaded onto the GSTrap™ HP column, and the flow-through
fractions were concentrated and purified by gel filtration on a Superdex™ 75 (GE
Healthcare) column. Selenomethionine-labeled Mt-PatA was expressed as described 39 and
purified in the presence of 1 mM tris(2-carboxyethyl)phosphine (TCEP).
M. smegmatis USP was expressed in BL21-CodonPlus E. coli cells induced with 0.5 mM
IPTG at 22 °C and purified as described above for Mt-PatA. His-tagged Rv1151c
deacetylase was expressed similarly, and harvested cells were resuspended in 20 mM
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tHEPES, pH 7.5, 500 mM NaCl, 25 mM imidazole and lysed by sonication. The cleared
lysate was purified on a Ni- charged HiTrap Chelating HP column (GE Healthcare) using a
25-300 mM imidazole gradient. The protein was concentrated and purified by gel filtration
on a Superdex™ 75 column in 20 mM Tris-HCl, pH 7.5, 100 mM NaCl.
In vitro protein acetylation and deacetylation assays
Acetylation assays were carried out in 20 mM buffer, 100 mM NaCl, 100 μM acetyl-CoA,
20 μM USP in the presence and absence of 200 μM cAMP. Reactions were initiated by the
addition of 20 μM Mt-PatA, incubated for 10 min at 22 °C, and quenched by boiling in SDS
loading dye. Buffers were as follows: sodium acetate (pH 4.0-5.0), MES (pH 6.0), HEPES
(pH 7.0), Tris (pH 7.5-8.0), BisTrisPropane (pH 9.0), and Glycine (pH 10.0). Reactions
were analyzed in parallel with SDS-PAGE and Western blotting with anti-AcLys antibody
(Cell Signaling Technology) detected quantitatively by chemiluminescence (LI-COR
Biosciences).
Deacetylation assays (20 μl) were carried out at 22 °C in 20 mM Tris-HCl, pH 7.5, 100 mM
NaCl, 1 mM β-Nicotinamide adenine dinucleotide (NAD+), 20 μM auto-acetylated Mt-PatA
H173K mutant in the presence and absence of 200 μM cAMP. Reactions were initiated by
addition of 5 μM Rv1151c and terminated at various time points by boiling in SDS loading
dye. Samples were analyzed in parallel using SDS-PAGE and Western blotting using SDS-
PAGE and Western blotting with anti-Ac-Lys antibodies.
His173Lys Mt-PatA auto-acetylation
The purified H173K Mt-PatA auto-acetylated in vivo was deacetylated twice sequentially
using Rv1151c deacetylase in 20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM NAD+, 10
μM Mt-PatA H173K, 200 μM cAMP and 5 μM His-tagged Rv1151c. The deacetylation
reaction was initiated by the addition of His-tagged Rv1151c to the reaction mixture and
incubated at 22 °C for 2 h. The reaction mixture was loaded onto a Ni-charged HiTrap
column and flow-through fractions were collected, followed by dialysis against 20 mM Tris-
HCl, pH 7.5, 100 mM NaCl overnight at 4 °C. Dialyzed protein was subjected to the second
deacetylation step using identical procedures to remove residual acetyl-Lys formed during
the dialysis due to the bound acetyl coenzyme-A carried over from cells in the course of
expression. The double-deacetylated H173K mutant was assayed for reacetylation in 20 mM
Tris-HCl, pH 7.5, 100 mM NaCl, 10 μM Mt- PatA H173K, 100 μM Ac-CoA in the
presence and absence of 200 μM cAMP. Samples were analyzed using SDS-PAGE and
Western blotting.
Comparison of activity with different CoA donors
Assays were carried out in 20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 μM Mt-PatA, 200
μM cAMP, 1 mM CoA donor(s) (Acetyl-, Propionyl-, and Butyryl-CoA), 100 μM M.
smegmatis USP. Masses of reaction products were determined using Liquid
Chromatography Mass Spectrometry (LC/MS).
Crystallization, structure determination and refinement
Mt-PatA:Ac-CoA was crystallized by vapor diffusion from 100 mM sodium cacodylate, pH
6.0, 200 mM magnesium acetate, 20% (w/v) PEG 8K. Two crystal forms of Mt-PatA:Ac-
CoA:cAMP were grown by vapor diffusion from 100 mM sodium citrate, pH 5.0, 5 mM
cAMP 12% (v/v) isopropanol, and 15% (w/v) PEG 10K. The crystals were transferred into
mother liquors containing 25% (v/v) ethylene glycol, and diffraction data were collected at
100 K. X-ray data were processed and scaled using HKL2000 40 or Mosflm 41 followed by
Scala 42.
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tThe structures of auto-inhibited and cAMP-activated Mt-PatA were solved using multi-
wavelength anomalous dispersion (MAD) phasing using Phenix AutoSol 43. Initial models
built by Phenix AutoBuild 43 were improved using ARP/wARP 44 and Coot 45. A model of
one molecule of the cAMP-bound form of Mt-PatA was used to place a second molecule in
the asymmetric unit using Phaser 46. Rigid body refinement 47 and automated modeling with
Buccaneer 48 were followed by additional cycles of manual model building and
refinement 43,47. The 1.8-Å-resolution cAMP-bound structure was determined using
molecular replacement 46 and refined using Phenix Refine 43 with exclusion of 5% of the
reflections to calculate Rfree. Translation/Libration/Screw (TLS) refinement was
incorporated at the end of the process. The molecules were packed similarly in the two
crystal forms of the activated enzyme.
Ringer correlation coefficients between electron-density maps of the active and auto-
inhibited structures were calculated as described 23,24. Models were validated using
Molprobity 49, showing 97.2-98.5% of all ϕ and ψ geometries are in the most favored
region, with no outlier in the Ramachandran statistics. Sequence conservation was mapped
onto the structures using ConSurf (http://consurf.tau.ac.il). The Pfam database (http://
pfam.sanger.ac.uk/) was used to identify functional domains and related sequences. Multiple
sequence alignment was performed using ClustalW2 50. Secondary structures were assigned
using DSSP (Dictionary of Protein Secondary Structure) 51, and structural figures were
generated using PyMOL (http://www.pymol.org/) and Chimera 52.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1. A double steric latch auto-inhibits Mt-PatA
(a) Overall fold of Mt-PatA. The N-terminal regulatory domain (yellow) is joined to the
catalytic PAT domain (magenta) by a short extended linker (red). A lid (cyan) inserted in the
PAT domain buries the catalytic site, and a helix appended to the C-terminus of the PAT
domain extends back to the regulatory domain and fills the cAMP-binding site. The bound
acetyl-CoA substrate (green) is shown in stick representation.
(b) The C-terminus occupies the cAMP-binding site in the regulatory domain. The surface
of the cAMP-binding site (dashed arrow) engages the protein C-terminus. The terminal
carboxylate of Gly333 and modeled cAMP are shown in stick representation. This figure is a
view of the box in Fig. 1a.
(c) Acetyl-CoA (spheres) binds in a shallow groove formed by conserved motifs of the PAT
domain 53.
(d) His173 (yellow) in the lid (cyan), contacts the catalytic base (Glu235, magenta), covers
the acetyl donor and mimics a lysine substrate. Acetyl-CoA (green) and side chains are
shown in stick model. The PAT domain is shown in magenta.
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tFigure 2. Crystal structure of the active form of Mt-PatA
(a) Difference-distance matrix between auto-inhibited and activated forms of Mt-PatA.
Colors represent Cα differences of −40 to 40 Å.
(b) Ribbon diagram of the auto-inhibited (left) and cAMP-activated (right) forms of Mt-
PatA. The regulatory (yellow) and catalytic domains (magenta) are dramatically reoriented,
and the lid (cyan) refolds. The C-terminal helix (blue) remains packed against the PAT
domain. The hinge in the interdomain linker, Ser144, is shown as a gray sphere. Bound Ac-
CoA (green) and cAMP (red) molecules are shown as sticks.
(c) Sequence conservation displayed on the surface of the activated form of Mt-PatA shows
that lid opening exposes a conserved surface (purple) around the acetyl donor site. Residues
conserved in mycobacterial Mt-PatA orthologs include central β-strands of the catalytic
domain and the residues binding the pantothenyl arm of acetyl-CoA. The view is the same
as the activated form of Fig. 2b.
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tFigure 3. Mechanisms of interdomain communication
(a) Regulatory domains of auto-inhibited (blue) and active (red, ’) states superimposed using
residues 37-113 reveal large shifts in the helical subdomain stabilized by cAMP (orange).
(b) Cyclic-AMP binds at the N-terminus of a short helix and contacts conserved residues
Glu89 and Arg98. Arg138 and Phe142 in helix F reorient to interact with the adenine ring.
(c) Rotamer flips mediate the large conformational change in the regulatory domain upon
binding cAMP (orange). Superimposed side chains (sticks) with Ringer correlation
coefficients <0.2 between the electron density maps of the auto-inhibited (blue) and active
(red) structures illustrate the extensive conformational remodeling. The backbone thickness
is proportional to the Cα difference.
(d) Residues on the active surface of Mt-PatA switch rotamers upon cAMP binding.
Dihedral angles (balls) with Ringer correlation coefficients <0.2 (pink) or <0 (red) between
the electron density maps of the active and auto-inhibited forms are displayed on the active
form. Ac-CoA (yellow) marks the catalytic site. Over 37% of residues have Ringer
correlation coefficients <0.2. Lid opening couples switches on the protein-substrate binding
surface in the PAT domain (top) to changes in the regulatory domain (bottom).
(e) The lid refolds to avoid a steric clash with the regulatory domain. The rotation of the
regulatory domain exposes the cAMP-binding site and opens the lid. Helix F interacts with
the helix I of the lid in the auto-inhibited state (blue), but changes stabilized by cAMP
eliminate contacts between these helices (’) in the activated state (red).
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tFigure 4. Mutants support a two-state model for Mt-PatA activation
(a) Auto-acetylation of His173Lys +/− cAMP. Purified His173Lys Mt-PatA (lane 1) was de-
acetylated, dialyzed and de-acetylated again with Rv1151c (lanes 2-4). The His173Lys
protein auto-acetylated efficiently in the absence but not presence of cAMP (lane 5-10).
(b) Acetylation of USP by His173Lys +/− cAMP shows that cAMP activates the mutant
enzyme to acetylate a heterologous substrate. USP alone (lane 1), or incubated with Mt-PatA
His173Lys variant in the absence or presence of cAMP (lanes 2 and 3).
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t(c) Deacetylation of Ac-His173Lys +/− cAMP and Ac-USP by Rv1151c +/− cAMP. Cyclic-
AMP indirectly stimulates deacetylation of the Mt-PatA His173Lys by stabilizing the open
conformation, but has no effect on deacetylation of USP.
(d) Activity of C-terminal-truncations/additions. Deletion of four residues (-4) or addition of
a Ser (+S) or Arg (+R) at the C-terminus activates Mt-PatA in the absence of cAMP. In
contrast, Ala substitutions of conserved residues that contact cAMP block activation. These
results emphasize the importance of the fit of the C-terminus into the regulatory site to form
a “latch” that stabilizes the auto-inhibited state relative to the active state.
(e) Changes in activity of mutants in the cAMP-binding-site (≤ residue 142) and lid (Arg184
and Phe185) reveal sites important to activate the enzyme.
Lee et al. Page 18
Nat Struct Mol Biol. Author manuscript; available in PMC 2013 February 01.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tFigure 5. The open lid in the active state uncovers a cavity for the substrate Lys
(a) Surface representation of the active conformation shows the access tunnel for the
substrate Lys. Residues in the lid (cyan) and the conserved catalytic domain (magenta) form
the surface surrounding the tunnel. Ac-CoA (sticks) projects the acetyl group (green C) and
the sulfur of the leaving group (gold) into the active site.
(b) Ribbon diagram of the binding surface for the substrate Lys in a same view and colors as
Fig. 5a. The Arg184-Arg223 hydrogen bond is shown as a dotted line.
(c) Catalytic site mutants reveal residues important for acetyl transfer. The pH dependence
of the activity of wild-type (activity at pH 8 ≥ pH 9) and Arg223Ala (activity at pH 9 > pH
8) variants suggest the importance of Arg223 in modulating the substrate Lys pKa.
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tFigure 6. A steric double-latch regulates Mt-PatA
Release of the steric double-latch stabilized by cAMP binding. The N-terminal regulatory
domain and the catalytic PAT domain are shown in yellow and magenta, respectively. The
lid is shown in cyan, and the C-terminal helix is shown in blue. Cooperative interdomain
communication is achieved indirectly, because the changes the regulatory domain stabilized
by cAMP are incompatible with the closed lid.
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